Fitch also affirmed the ‘AA’ ratings on the following revenue bonds issued by the New Mexico Hospital Equipment Loan Council for the benefit of PHS: $75 million of series 2012A hospital revenue bonds, $134.6 million of series 2009A hospital revenue bonds, $139.4 million of series 2008A hospital revenue bonds, and $200.1 million of series 2008B-D hospital revenue bonds.
Here are five things to know about the rating and PHS’ outlook:
1. The rating assignment was supported by a number of factors, including the strategic benefits of PHS’ vertically aligned healthcare delivery network (includes eight acute care facilities, a 600+ provider employed medical group and a 443,000-member health plan) which is further bolstered by a strong liquidity position.
2. The rating assignment was also supported by PHS’ position as the market share leader in the Albuquerque metropolitan area
3. Fitch expects PHS to deliver “consistent financial results that are in line for an “AA” rated credit as it maximizes its vertically integrated delivery platform.”
4. Fitch said while not anticipated, a material weakening in profitability over a prolonged period could pressure the rating.
5. PHS’ outlook is stable.
More articles on healthcare finance:
Kenneth Kaufman: Beyond healthcare’s tipping point
Surviving the “New Normal” for Orthopedic Practice in 2015
What SpongeBob can teach us about the cost of healthcare
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
